President Trump offered an uplifting story about drug approvals during his Feb. 28 address at a joint session of Congress, but unfortunately for FDA, it was the villain in the piece, with "burdensome" agency restrictions becoming a key example in Trump’s criticism of government over-regulation.
Trump featured in the audience a rare disease survivor – 20-year-old Megan Crowley – who suffers from Pompe disease, an inherited disorder caused by the buildup of glycogen in the body's cells
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?